In thyroid carcinoma patients, CYP1A1 could serve as a prognostic marker to point to the grade of tumor severity, with the CYP1A1 gene expression associated with tumor size, the presence of metastasis, and advanced clinical stage (GallegosVargas et al., 2016). Here, CYP1A1 is linked to neoplasm.